S&P 500   3,819.72 (-1.31%)
DOW   31,270.09 (-0.39%)
QQQ   309.22 (-2.88%)
AAPL   122.04 (-2.46%)
MSFT   227.45 (-2.75%)
FB   255.41 (-1.39%)
GOOGL   2,011.39 (-2.57%)
TSLA   652.00 (-5.02%)
AMZN   3,005.20 (-2.89%)
NVDA   512.28 (-4.47%)
BABA   236.27 (+0.79%)
CGC   33.26 (-5.65%)
GE   13.46 (+3.70%)
MU   88.88 (-2.43%)
NIO   41.87 (-3.28%)
AMD   81.10 (-3.60%)
T   28.72 (+1.77%)
F   12.18 (-2.95%)
ACB   10.47 (-5.08%)
DIS   190.88 (-1.58%)
BA   228.45 (+2.38%)
NFLX   521.70 (-4.77%)
PFE   34.37 (+2.57%)
S&P 500   3,819.72 (-1.31%)
DOW   31,270.09 (-0.39%)
QQQ   309.22 (-2.88%)
AAPL   122.04 (-2.46%)
MSFT   227.45 (-2.75%)
FB   255.41 (-1.39%)
GOOGL   2,011.39 (-2.57%)
TSLA   652.00 (-5.02%)
AMZN   3,005.20 (-2.89%)
NVDA   512.28 (-4.47%)
BABA   236.27 (+0.79%)
CGC   33.26 (-5.65%)
GE   13.46 (+3.70%)
MU   88.88 (-2.43%)
NIO   41.87 (-3.28%)
AMD   81.10 (-3.60%)
T   28.72 (+1.77%)
F   12.18 (-2.95%)
ACB   10.47 (-5.08%)
DIS   190.88 (-1.58%)
BA   228.45 (+2.38%)
NFLX   521.70 (-4.77%)
PFE   34.37 (+2.57%)
S&P 500   3,819.72 (-1.31%)
DOW   31,270.09 (-0.39%)
QQQ   309.22 (-2.88%)
AAPL   122.04 (-2.46%)
MSFT   227.45 (-2.75%)
FB   255.41 (-1.39%)
GOOGL   2,011.39 (-2.57%)
TSLA   652.00 (-5.02%)
AMZN   3,005.20 (-2.89%)
NVDA   512.28 (-4.47%)
BABA   236.27 (+0.79%)
CGC   33.26 (-5.65%)
GE   13.46 (+3.70%)
MU   88.88 (-2.43%)
NIO   41.87 (-3.28%)
AMD   81.10 (-3.60%)
T   28.72 (+1.77%)
F   12.18 (-2.95%)
ACB   10.47 (-5.08%)
DIS   190.88 (-1.58%)
BA   228.45 (+2.38%)
NFLX   521.70 (-4.77%)
PFE   34.37 (+2.57%)
S&P 500   3,819.72 (-1.31%)
DOW   31,270.09 (-0.39%)
QQQ   309.22 (-2.88%)
AAPL   122.04 (-2.46%)
MSFT   227.45 (-2.75%)
FB   255.41 (-1.39%)
GOOGL   2,011.39 (-2.57%)
TSLA   652.00 (-5.02%)
AMZN   3,005.20 (-2.89%)
NVDA   512.28 (-4.47%)
BABA   236.27 (+0.79%)
CGC   33.26 (-5.65%)
GE   13.46 (+3.70%)
MU   88.88 (-2.43%)
NIO   41.87 (-3.28%)
AMD   81.10 (-3.60%)
T   28.72 (+1.77%)
F   12.18 (-2.95%)
ACB   10.47 (-5.08%)
DIS   190.88 (-1.58%)
BA   228.45 (+2.38%)
NFLX   521.70 (-4.77%)
PFE   34.37 (+2.57%)
Log in
OTCMKTS:SONVY

Sonova Stock Forecast, Price & News

$52.02
+0.59 (+1.15 %)
(As of 03/2/2021 12:00 AM ET)
Add
Compare
Today's Range
$51.93
Now: $52.02
$52.17
50-Day Range
$48.30
MA: $51.29
$54.02
52-Week Range
$29.41
Now: $52.02
$54.77
Volume17,655 shs
Average Volume17,824 shs
Market Capitalization$16.75 billion
P/E Ratio34.91
Dividend YieldN/A
Beta0.7
Sonova Holding AG designs, develops, manufactures, and distributes hearing systems for adults and children with hearing impairment. It operates through two segments, Hearing Instruments and Cochlear Implants segments. It offers wireless communication products, rechargeable hearing aids, and professional audiological care services. The company provides hearing instruments under the Phonak, Unitron, and Hansaton brand names; cochlear implants under the Advanced Bionics brand; and professional hearing care services under the AudioNova, Audium, AuditionSanté, Boots Hearingcare, Connect Hearing, Fiebing, Geers, Hansaton, Lapperre, Lindacher, Schoonenberg, Triton, and Vitakustik brands. Sonova Holding AG sells its products through wholesale companies and independent distributors; and provides professional audiological care services through a network of approximately 3,500 stores and clinics. It operates in the Americas, Europe, the Middle East, Africa, and the Asia/Pacific. The company was formerly known as Phonak Holding AG and changed its name to Sonova Holding AG in August 2007. Sonova Holding AG was founded in 1947 and is headquartered in Stäfa, Switzerland.
Sonova logo

Headlines

Sonova Holding AG ADR (SONVY)
October 18, 2020 |  nasdaq.com
Sonova Holding AG ADR
October 10, 2019 |  www.barrons.com
See More Headlines

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:SONVY
CUSIPN/A
CIKN/A
Phone41-58-928-3333
Employees14,349
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.96 billion
Cash Flow$2.17 per share
Book Value$6.35 per share

Profitability

Miscellaneous

Market Cap$16.75 billion
Next Earnings DateN/A
OptionableNot Optionable

MarketRank

Overall MarketRank

0.88 out of 5 stars

Medical Sector

1092nd out of 1,968 stocks

Electromedical Equipment Industry

31st out of 61 stocks

Analyst Opinion: 0.0Community Rank: 1.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 2.5 5 -4 -3 -2 -1 -
$52.02
+0.59 (+1.15 %)
(As of 03/2/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SONVY News and Ratings via Email

Sign-up to receive the latest news and ratings for SONVY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Sonova (OTCMKTS:SONVY) Frequently Asked Questions

Is Sonova a buy right now?

9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Sonova in the last twelve months. There are currently 6 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Sonova stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SONVY, but not buy additional shares or sell existing shares.
View analyst ratings for Sonova
or view top-rated stocks.

What stocks does MarketBeat like better than Sonova?

Wall Street analysts have given Sonova a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Sonova wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Sonova?

Sonova saw a increase in short interest in February. As of February 12th, there was short interest totaling 9,100 shares, an increase of 26.4% from the January 28th total of 7,200 shares. Based on an average daily volume of 25,000 shares, the short-interest ratio is currently 0.4 days.
View Sonova's Short Interest
.

How has Sonova's stock price been impacted by COVID-19?

Sonova's stock was trading at $44.21 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, SONVY shares have increased by 17.7% and is now trading at $52.0215.
View which stocks have been most impacted by COVID-19
.

Who are Sonova's key executives?

Sonova's management team includes the following people:
  • Mr. Arnd Kaldowski, CEO, COO & Member of Management Board (Age 54)
  • Dr. Hartwig Grevener, CFO & Member of Management Board (Age 55)
  • Mr. Andi Vonlanthen, Group VP of R&D and Member of Management Board (Age 60)
  • Mr. Claude Diversi, Group VP of Hearing Instruments Wholesale & Member of Management Board (Age 57)
  • Mr. Martin Grieder, Group VP of Hearing Instruments Marketing & Member of Management Board (Age 56)
  • Mr. Christophe Fond, Group VP of Audiological Care & Member of Management Board (Age 55)
  • Mr. Claudio Bartesaghi, Group VP of Corp. HRM & Communications and Member of Management Board (Age 48)
  • Dr. Victoria E. Carr-Brendel, Member of Management Board, Group VP of Cochlear Implants & Pres of Advanced Bionics (Age 57)
  • Mr. Ludger Althoff, Group VP of Operations & Member of Management Board (Age 57)
  • Mr. Thomas Bernhardsgrutter, Director of Investor Relations

Who are some of Sonova's key competitors?

What is Sonova's stock symbol?

Sonova trades on the OTCMKTS under the ticker symbol "SONVY."

How do I buy shares of Sonova?

Shares of SONVY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Sonova's stock price today?

One share of SONVY stock can currently be purchased for approximately $52.02.

How much money does Sonova make?

Sonova has a market capitalization of $16.75 billion and generates $2.96 billion in revenue each year. The company earns $489.96 million in net income (profit) each year or $1.49 on an earnings per share basis.

How many employees does Sonova have?

Sonova employs 14,349 workers across the globe.

What is Sonova's official website?

The official website for Sonova is www.sonova.com.

Where are Sonova's headquarters?

Sonova is headquartered at Laubisrutistrasse 28, Stafa V8, 8712.

How can I contact Sonova?

Sonova's mailing address is Laubisrutistrasse 28, Stafa V8, 8712. The company can be reached via phone at 41-58-928-3333 or via email at [email protected]


This page was last updated on 3/3/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.